Cargando…
Targeting GATA4 for cardiac repair
Various strategies have been applied to replace the loss of cardiomyocytes in order to restore reduced cardiac function and prevent the progression of heart disease. Intensive research efforts in the field of cellular reprogramming and cell transplantation may eventually lead to efficient in vivo ap...
Autores principales: | Välimäki, Mika J., Ruskoaho, Heikki J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973159/ https://www.ncbi.nlm.nih.gov/pubmed/31419020 http://dx.doi.org/10.1002/iub.2150 |
Ejemplares similares
-
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line
por: Välimäki, Mika J., et al.
Publicado: (2021) -
Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
por: Kinnunen, Sini M., et al.
Publicado: (2018) -
GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes
por: Karhu, S. Tuuli, et al.
Publicado: (2020) -
Nuclear Receptor-Like Structure and Interaction of Congenital Heart Disease-Associated Factors GATA4 and NKX2-5
por: Kinnunen, Sini, et al.
Publicado: (2015) -
Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds
por: Karhu, S. Tuuli, et al.
Publicado: (2018)